Virginia Tech® home

Cell and Gene Therapy Commercialization: Lessons Learned from a CEO

Insert your title here

Your Text Here
Sue Washer

Sue Washer, MBA

Former President and CEO
Applied Genetics Technologies Corp.
Member, SEC Small Business Capital Formation Advisory Committee
Member, Board of Directors, BioFlorida
View Speaker Profile

Cell and Gene Therapy Commercialization: Lessons Learned from a CEO

Date: April 28, 2026

Time:  2 p.m.

Room 3012, 2 Riverside Circle, Fralin Biomedical Research Institute at VTC

Watch via Zoom

About this Seminar

Sue Washer is the former president and CEO of Applied Genetics Technologies Corp. (AGTC). During her more than 20 years there, she was prominently involved in the University of Florida and state of Florida start-up ecosystem. AGTC was a clinical-stage biotechnology company focused on developing Adeno-associated virus (AAV)-based gene therapies for rare, inherited retinal diseases. It was sold in 2022 to Syncona, which ultimately launched Beacon Therapeutics with the AGTC gene therapy assets. She brings a decade of experience in pharmaceutical management and research with Abbott Labs and Eli Lilly & Co., with an additional nine years of senior management experience with entrepreneurial firms. At AGTC, she secured private and public investments of more than $290 million, negotiated and closed two major collaborations with top biotech companies resulting in more than $150 million of cash in-flows, and led AGTC in efficiently completing critical scientific milestones. She is an appointed member of the Small Business Capital Formation Advisory Committee for the SEC, past associate vice president of the ECSGB Board of Bio, and currently serves as a director of BioFlorida. She earned her undergraduate degree in biochemistry from Michigan State University and her MBA from the University of Florida, where she was one of the first graduates from the Warrington College of Business Entrepreneurship program.

You May Also Be Interested In...

  • Home Item
    Exercise, the Fountain of Youth?
    Exercise, the Fountain of Youth? , home

    Oct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture

  • Home Item
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , home

    Oct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.

  • Home Item
    Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons
    Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons , home

    Oct. 30, 2026, 11:00 a.m. | Elly Nedivi, Ph.D., William R. (1964) & Linda R. Young Professor of Neuroscience, The Picower Institute for Learning & Memory, Departments of Brain and Cognitive Sciences, and Biology, Massachusetts Institute of Technology | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Neurobiology Research

  • Home Item
    Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish
    Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish , home

    Nov. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Joseph Wu, M.D., Ph.D., Professor and Director, Stanford Cardiovascular Institute, Stanford University School of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    Presenting Therapeutic Peptides Using Synthetic Polymers
    Presenting Therapeutic Peptides Using Synthetic Polymers , home

    Nov. 13, 2026, 11:00 a.m. | Rachel A. Letteri, Ph.D., Associate Professor, Departments of Chemical Engineering, University of Virginia | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research

  • Home Item
    The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function
    The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , home

    Dec. 11, 2026, 11:00 a.m. | Paule V. Joseph, Ph.D., MBA, Lasker Clinical Research Scholar, NIH Distinguished Scholar, Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD; Co-Director, National Smell and Taste Center; Attending Nurse Practitioner, Division of Intramural Clinical and Biological Research; National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and Other Communication Disorders | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research